The FDA approved a new indication for liraglutide to reduce the risk of myocardial infarction, stroke, and cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. ... The FDA recently approved a new indication for
The FDA has identified 12 cases of necrotizing fasciitis of the perineum or Fournier's gangrene. ... The FDA warned on Aug. 29 that cases of a rare, serious infection of the genitals and surrounding area have been reported in patients taking
Certain batches of NovoPen Echo insulin cartridge holders are being recalled by the manufacturer because they may crack or break if exposed to certain chemicals, such as cleaning agents, the FDA ... The FDA also announced on May 19 that it approved the
Canagliflozin (Invokana, Invokamet) increases patients' risk of leg and foot amputations, according to new data from two clinical trials, the FDA recently announced. ... Canagliflozin (Invokana, Invokamet) increases the risk of leg and foot amputations
The first FDA-approved continuous glucose monitoring system with a fully implantable glucose sensor has been cleared for use in adults with diabetes, the agency announced on June 21.
Patients should not use unapproved or unauthorized devices for diabetes management, either alone or with authorized devices, the FDA recently warned. ... In one report, a patient used an unauthorized device that received the electronic signal from an
The clinical study did not meet its original end point, but the FDA concluded that the benefits outweighed risks of the device, according to a press release. ... Other adverse events included pain, heartburn, problems swallowing, belching, mild nausea,